Experts Tell Hawaii Lawmakers to localize CBD Industry for Public Safety

September 16, 2019 15:00:29

Different experts addressed Hawaii lawmakers on Thursday in order to educate them about the potential benefits of CBD as well as the risks of the products that are flooding the Hawaii market.

State Rep. John Mizuno, the chairman of the Hawaii House Health Committee, stated during the hearing that the lawmakers aren’t opposed to CBD. Instead, they want to see that adequate protections are in place to ensure that consumers are safe.

Many CBD products that are available on the market have labels claiming that those products have been subjected to laboratory tests, but it is hard for a layperson to verify that this claim is accurate.

Michael Backes, a research who addressed the Hawaii lawmakers, revealed that cheap CBD isolate powder sourced from China and Eastern Europe dominates the products that people are currently buying in retail outlets and online.

Backes adds that the isolate powder is shipped in 75 gallon drums to different ports across the U.S., then the isolate is packaged and sold to Americans. It is hard to know what is inside the bottle you have bought if the products weren’t subjected to rigorous testing from their source.

Earlier last month, one Hawaii teenager was hospitalized after developing severe lung damage that some health professionals think is connected to vaping tainted marijuana oil.

Backes believes that the best way to avert such cases is by localizing the CBD industry so that all the products that get to the local market can be tested before they are sold.

Michael Backes wants Hawaii to pass a CBD law so that the expertise of the state agricultural officials and academic institutions can be harnessed for the benefit of the consumers and the business community.

If that isn’t done, lawmakers on the Health Committee warn that products of questionable quality may keep finding their way onto the local market and the public may be put at risk.

Furthermore, the absence of local CBD laws deters hemp growers and processors from operating in Hawaii since it may be hard for them to determine the long-term viability of the industry in a climate that leaves the door open to any product.

If the state decides to legalize CBD, the expert testimony seems to suggest that the law should allow processors and manufacturers to put CBD in various edibles, beverages and supplements. This approach differs from what other states, such as Washington State, have opted for, which is to ban the use of CBD in food, beverages and supplements until the FDA decides how to regulate cannabidiol (CBD).

Industry watchers believe CBD industry players like Marijuana Company of America Inc. (OTCQB: MCOAD) and Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) would also agree that some form of regulation is necessary so that public safety is guaranteed.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office